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Abstract	
Current	 pharmaceutical	 formulation	 development	 still	 strongly	 relies	 on	 the	 traditional	 trial-and-error	
approach	by	individual	experiences	of	pharmaceutical	scientists,	which	is	laborious,	time-consuming	and	
costly.	 Recently,	 deep	 learning	 has	 been	 widely	 applied	 in	 many	 challenging	 domains	 because	 of	 its	
important	capability	of	automatic	feature	extraction.	The	aim	of	this	research	is	to	use	deep	learning	to	
predict	pharmaceutical	formulations.	In	this	paper,	two	different	types	of	dosage	forms	were	chosen	as	
model	systems.	Evaluation	criteria	suitable	for	pharmaceutics	were	applied	to	assessing	the	performance	
of	 the	 models.	 Moreover,	 an	 automatic	 dataset	 selection	 algorithm	 was	 developed	 for	 selecting	 the	
representative	data	as	validation	and	test	datasets.	Six	machine	learning	methods	were	compared	with	
deep	learning.	The	result	shows	the	accuracies	of	both	two	deep	neural	networks	were	above	80%	and	
higher	 than	 other	 machine	 learning	 models,	 which	 showed	 good	 prediction	 in	 pharmaceutical	
formulations.	In	summary,	deep	learning	with	the	automatic	data	splitting	algorithm	and	the	evaluation	
criteria	 suitable	 for	 pharmaceutical	 formulation	 data	 was	 firstly	 developed	 for	 the	 prediction	 of	
pharmaceutical	 formulations.	 The	 cross-disciplinary	 integration	 of	 pharmaceutics	 and	 artificial	
intelligence	may	shift	the	paradigm	of	pharmaceutical	researches	from	experience-dependent	studies	to	
data-driven	methodologies.	
[Keywords]	 pharmaceutical	 formulation;	 deep	 learning;	 small	 data;	 automatic	 dataset	 selection	
algorithm;	oral	fast	disintegrating	films;	oral	sustained	release	matrix	tablets.	
	 	
1.	Introduction	
The	 current	 pharmaceutical	 industry	 faces	 the	 great	 pressure	 of	 reduced	 healthcare	 costs	 and	 less	
number	 of	 new	 active	 pharmaceutical	 ingredients	 (APIs).	 The	 pharmaceutical	 industry	 should	 employ	
more	 efficient	 and	 systematic	 ways	 in	 both	 drug	 discovery	 and	 development	 processes.1	 In	 drug	
discovery	 area,	 scientists	 now	 widely	 use	 high-throughput	 screening,	 combinatorial	 chemistry,	 and	
computer-aided	 drug	 design	 to	 accelerate	 drug	 discovery	 and	 development.2	 However,	 nowadays,	
pharmaceutical	formulation	development	still	strongly	relies	on	the	traditional	trial-and-error	approach	
by	 individual	 experiences	 of	 pharmaceutical	 scientists,	 which	 is	 laborious,	 time-consuming	 and	 cost-
expensive.	Moreover,	it	is	difficult	to	achieve	the	optimum	formulations	by	the	trial-and-error	studies	in	
the	 laboratory.	 Simplification	of	 formulation	development	becomes	essential	 to	 formulation	 scientists.	
Thus,	it	is	necessary	to	develop	an	efficient	and	systematic	method	for	formulation	development	to	keep	
pace	with	the	requirements	of	the	pharmaceutical	industry.3		
Machine	learning	is	one	of	the	most	exciting	research	areas	in	recent	years.	Machine	learning	can	make	
data-driven	predictions	with	existed	experimental	data,	which	provides	a	great	opportunity	for	efficient	
formulation	 development.4-9	 A	 well-designed	 machine	 learning	 method	 can	 greatly	 speed	 the	
development,	 optimize	 formulations,	 save	 the	 cost,	 keep	 products	 consistency,	 and	 accumulate	 and	
preserve	 the	 specific	 knowledge	 and	 expertise	 from	 the	 experts	 in	 a	 well-defined	 domain.4	 Table	 1	
summarizes	recent	progress	of	machine	learning	in	formulation	design.	Expert	systems	(ESs)	and	artificial	
neural	 networks	 (ANNs)	 were	 two	 useful	 tools	 for	 the	 formulation	 development.	 4-6,	 8,	 9	 An	 ES	 is	 an	
intelligent	program	with	the	ability	 to	accumulate	and	preserve	the	knowledge	and	experiences	of	 the	
experts	 in	 a	 specific	 area	 (e.g.,	 pharmaceutical	 formulations).10	 However,	 it	 is	 difficult	 to	 extract	 the	
vague	experiences	of	 pharmaceutical	 experts	 into	 the	 rules	 of	 ESs,	 and	 then	 to	 accurately	 predict	 the	
performance	 of	 a	 formulation.	 ANN	 was	 the	 most	 popular	 machine	 learning	 tool	 in	 pharmaceutical	
formulation	prediction.	ANN	simulates	the	structure	and	functions	of	biological	neural	networks.5	ANN	is	
able	to	solve	the	problems	that	are	hard	to	be	solved	by	standard	expert	systems.5	However,	ANNs	still	
need	 strong	 expert	 knowledge	 to	 design	 feature	 extractors	 in	 the	 prediction	 process.	 In	 addition,	 the	
formulation	prediction	accuracy	by	ANNs	is	relatively	low	due	to	the	limited	experimental	data.		
	
	
	
Table	1	Recent	progress	of	machine	learning	in	formulation	design	
Machine	learning	techniques	 Formulation	 Reference	
Hybrid	expert	system	with	ANNs	 Hard	gelatin	capsule	formulations	 11	
Expert	system	(SeDeM	Diagram)	 Orally	disintegrating	tablets	 12,	13	
Expert	system	with	ANNs	 Osmotic	pump	tablets	 5,	14	
Ontology-based	expert	system	 Immediate	Release	Tablets	 15	
ME_expert	2.0	 Microemulsions	formulations	 6	
Fuzzy	logic-based	expert	system	 Freeze-dried	formulations	 16	
Cubist	and	Random	Forest	 Cyclodextrin	formulations	 17	
	
Deep	 learning	 as	 an	 automatic	 general-purpose	 learning	 procedure	 has	 been	widely	 adopted	 in	many	
domains	 of	 science,	 business,	 and	 government.18	 Unlike	 other	 machine	 learning	 techniques	 with	 the	
requirement	of	domain	expertise	to	design	feature	extractors,	deep	learning	can	automatically	transform	
low-level	representation	to	more	abstract	level.19	Moreover,	deep	learning	is	more	sensitive	to	irrelevant	
and	particular	minute	variations,	which	make	deep	learning	methods	reach	higher	accuracy	rather	than	
other	 machine	 learning	 methods.20	 Deep	 convolutional	 networks	 inspired	 from	 visual	 neuroscience	
usually	 achieve	 good	 results	 for	 processing	 images,	 video,	 speech,	 and	 audio.21,	 22	 Recurrent	 neural	
networks	 containing	 history	 information	 of	 the	 sequence	 have	 brought	 about	 the	 breakthrough	 in	
sequential	 data,	 such	 as	 text	 and	 speech.23,	 24	 Pharmaceutical	 formulation	 data	 include	 formulation	
compositions	and	manufacturing	process,	which	are	neither	image	data	nor	sequential	data.	Therefore,	
the	 full-connected	 deep	 feed-forward	 network	 is	 a	 good	 choice	 for	 the	 prediction	 of	 pharmaceutical	
formulations.	 The	 recent	 study	 showed	 that	 deep	 neural	 networks	 (DNNs)	made	 better	 performance	
than	ANNs	with	one	hidden	 layer	 in	oral	 disintegrating	 tablet	prediction.25	 The	Maximum	Dissimilarity	
algorithm	 with	 the	 small	 group	 filter	 and	 representative	 initial	 set	 selection	 (MD-FIS)	 selected	 the	
representative	 validation	 set	 from	 the	 small	 and	 imbalanced	 oral	 disintegrating	 tablet	 data.	 However,	
more	comparisons	of	deep	learning	with	other	machine	learning	methods	for	formulation	prediction	are	
still	lacked.	
In	the	past	five	years	there	are	increasing	applications	of	deep	learning	in	pharmaceutical	researches.26-29	
The	first	study	of	deep	learning	in	pharmaceutical	research	in	2013	was	to	compare	deep	learning	with	
other	machine	learning	approaches	by	predicting	the	water	solubility	of	drugs.30	The	results	showed	that	
deep	 learning	 had	 better	 performance	 than	 other	 approaches.	 After	 that,	 more	 pharmaceutical	
applications	of	deep	learning	were	reported.	For	example,	a	deep	convolution	network	was	developed	to	
predict	 the	 epoxidation	 reactivity	 of	 molecules	 to	 reduce	 the	 drug	 toxicity.31	 Deep	 learning	 was	 also	
applied	 for	 the	 prediction	 of	 drug-induced	 liver	 injury	 with	 good	 performance.32	 Another	 study	 also	
showed	 that	deep	 learning	performed	better	 in	 toxicity	prediction	 than	other	 computational	methods	
(naive	 Bayes,	 support	 vector	 machines,	 and	 random	 forests)	 in	 2016	 Tox21	 Data	 Challenge.	 Deep	
learning	 was	 also	 used	 in	 drug	 discovery.33-35	 DNNs	 were	 able	 to	make	 better	 predictions	 than	 other	
machine	 learning	 approaches	 on	 quantitative	 structure	 activity	 relationships	 (QSAR)	 data	 sets.33	
Moreover,	 multitask	 deep	 learning	 and	 one-shot	 learning	 approaches	 were	 used	 in	 low	 data	 drug	
discovery,	 which	 had	 better	 performance	 than	 single-task	 learning.34,	 35	 In	 addition,	 applying	 deep	
learning	to	mine	the	increasing	datasets	in	drug	discovery	not	only	enables	us	to	learn	from	the	past	but	
to	predict	future	drug	repurposing.36,	37	Recently,	the	performance	of	five	machine	learning	models	and	
four	DNNs	with	2,	3,	4,	5	hidden	layers	were	evaluated	on	8	datasets.38	Further	analysis	was	carried	out	
by	using	the	ranked	normalized	scores	including	seven	classic	measurements	of	model	performance.	The	
final	 results	of	 the	scores	 ranked	by	metric	and	by	dataset	 indicated	 that	 the	DNNs	with	 five	and	 four	
hidden	 layers	made	better	performance	 than	other	machine	 learning	approaches.	Nearly	all	 reports	 in	
recent	 5	 years	 suggested	 that	 deep	 learning	 had	more	 benefits	 in	 predictive	 performance	 than	 other	
machine	learning	methods.	
In	 this	 paper,	 deep	 learning	 was	 applied	 to	 pharmaceutical	 formulation	 prediction	 by	 constructing	
regression	 models.	 One	 of	 the	 main	 difficulties	 in	 formulation	 prediction	 is	 the	 small	 dataset	 with	
imbalanced	input	space	due	to	the	limited	experimental	data.	For	better	performance,	the	data	splitting	
algorithm	and	the	evaluation	criteria	suitable	for	pharmaceutical	formulation	data	were	introduced.	The	
DNNs	 were	 trained	 on	 the	 data	 of	 two	 types	 of	 pharmaceutical	 dosage	 forms,	 including	 oral	 fast	
disintegrating	 films	 (OFDF)	 and	 oral	 sustained	 release	 matrix	 tablets	 (SRMT).	 Comparisons	 of	 deep	
learning	with	 other	 six	machine	 learning	 techniques	were	 carried	 out.	 Compared	with	 other	machine	
learning	 methods,	 deep	 learning	 can	 find	 out	 the	 intricate	 correlation	 between	 pharmaceutical	
formulations	 and	 in	 vitro	 characteristics,	 which	 shows	 wide	 prospects	 for	 the	 application	 of	 deep	
learning	in	pharmaceutical	formulation	prediction.	
	2.	Methods	
2.1.	Pharmaceutical	Data	
The	 pharmaceutical	 dataset	 includes	 131	 formulations	 of	 OFDF	 and	 145	 formulations	 of	 SRMT.	 The	
experimental	 data	were	 extracted	 from	Web	 of	 Science.	 Three	 different	 searching	 terms	 of	 oral	 fast-
dissolving	films,	oral	disintegrating	films	and	orodispersible	films	were	used	for	search	literatures	about	
the	development	of	OFDF	formulations.	The	searching	strategy	of	Hydroxypropyl	methyl	cellulose	(HPMC)	
based	sustained	release	matrix	tablet	formulations	was	“HPMC”	or	"Hydroxypropyl	methylcellulose"	or	
“hydroxypropylmethylcellulose”	 or	 "hydroxypropylmethyl	 cellulose"	 or	 “hypromellose”	 and	 “tablet”	 or	
“tablets”.	 The	 formulation	 data	 contain	 types	 and	 contents	 of	 both	 drugs	 and	 excipients,	 process	
parameters	 and	 in	 vitro	 characteristics	 of	 dosage	 forms.	 The	 characteristics	 of	 the	 two	 dosage	 forms	
were	 chosen	 as	 the	 prediction	 targets	 in	 this	 research,	 including	 disintegration	 time	 for	 OFDF	 and	
cumulative	dissolution	profiles	(2,	4,	6	and	8	hours)	for	SRMT.		
The	 molecular	 descriptors	 were	 used	 for	 representing	 the	 properties	 of	 APIs.	 All	 drugs’	 name	 were	
described	 with	 the	 nine	 molecular	 descriptors,	 including	 molecular	 weight,	 XLogP3,	 hydrogen	 bond	
donor	count,	hydrogen	bond	acceptor	count,	rotatable	bond	count,	topological	polar	surface	area,	heavy	
atom	count,	complexity	and	logS.	The	excipient	types	were	encoded	to	different	numbers.	The	process	
parameters	 include	 weight,	 thickness,	 tensile	 strength,	 elongation,	 folding	 endurance,	 actual	 drug	
content	of	OFDF	and	granulation	process,	diameter,	hardness	of	SRMT.	
2.2.	Data	Splitting	Strategy	
Three-dataset	 (training/validation/test	 datasets)	 splitting	 strategy	was	 used	 in	 this	 paper.	 The	 training	
set	is	for	training	models,	and	the	validation	set	is	for	tuning	hyper-parameters	to	find	the	best	model.	
The	 accuracy	 of	 the	 test	 set	 shows	 the	 prediction	 ability	 on	 unknown	 data.	 This	 strategy	 is	 widely	
adopted	 in	 machine	 learning.	 For	 each	 dosage	 form,	 the	 pharmaceutical	 data	 were	 split	 into	 three	
subsets,	both	the	validation	set	and	the	test	set	include	20	formulations,	the	rest	of	the	data	were	used	
to	train	the	models.	
2.3.	Hyperparameters	of	Machine	Learning	Methods	
Six	machine	 learning	methods	were	 introduced	to	construct	regression	models	to	compare	with	DNNs,	
including	 multiple	 linear	 regression	 (MLR),	 partial	 least	 squared	 regression	 (PLSR),	 support	 vector	
machine	 (SVM),	 ANNs,	 random	 forest	 (RF)	 and	 k-nearest	 neighbors	 (k-NN).	 These	 regression	 models	
were	trained	using	the	scikit-learn	package.39	For	OFDF,	in	PLSR,	the	number	of	components	was	set	to	8.	
In	ANNs,	the	networks	contained	1	hidden	layer	with	80	hidden	nodes.	In	RF,	the	maximum	depth	of	the	
tree	was	 set	 to	 3.	 In	 k-NN,	 the	 number	 of	 neighbors	was	 set	 to	 5.	 For	 SRMT,	 4	models	were	 trained	
simultaneously	 for	 4	 time	points	 (2,	 4,	 6	 and	8	hours)	 by	using	 each	machine	 learning	method.	 The	4	
models	were	developed	using	the	same	hyperparameters.	 In	PLSR,	the	number	of	components	was	set	
to	10.	In	ANNs,	the	networks	contained	1	hidden	layer	with	60	hidden	nodes.	In	RF,	the	maximum	depth	
of	the	tree	was	set	to	5.	In	k-NN,	the	number	of	neighbors	was	set	to	3.	
2.4.	Hyperparameters	of	Deep	Neural	Networks	
DeepLearning4j	machine	learning	framework	(https://deeplearning4j.org/)	was	used	to	train	the	deep	neural	
networks.	 For	OFDF,	a	 feed-forward	neural	network	with	10	 layers	and	900	epochs	was	adopted.	This	
network	 contained	 50	 hidden	 nodes	 on	 each	 layer.	 For	 SRMT,	 a	 feed-forward	 neural	 network	with	 9	
layers	 and	 2600	 epochs	 was	 adopted.	 This	 network	 contained	 30	 hidden	 nodes	 on	 each	 layer.	 All	
networks	 chose	 tanh	 as	 the	 activation	 function	 except	 the	 last	 layer	with	 sigmoid	 activation	 function.	
Learning	 rate	 was	 0.01.	 Batch	 gradient	 descent	 with	 the	 0.8	momentum	 was	 used	 for	 training	 these	
networks.	
2.5.	Evaluation	Criteria	
In	 machine	 learning,	 correlation	 coefficient	 and	 coefficient	 of	 determination	 are	 usually	 adopted	 as	
evaluation	 metrics	 for	 regression	 problems.	 Correlation	 coefficient	 indicates	 the	 linear	 relationship	
between	 two	variables.	The	coefficient	of	determination	shows	 the	correlation	between	 the	predicted	
values	 and	 the	 real	 values.	 However,	 the	 correlation	 coefficient	 and	 the	 coefficient	 of	 determination	
cannot	 well	 evaluate	 the	 performance	 of	 the	 pharmaceutical	 formulation	 prediction	 models.	 In	
pharmaceutics	the	good	models	for	predicting	drug	dissolution	profiles	should	have	less	than	10%	error	
40	 Thus,	 specific	 criteria	 suitable	 for	 pharmaceutics	 should	 be	 introduced	 to	 evaluate	 the	 model	
performance.		
Following	the	FDA	(the	U.S.	Food	and	Drug	Administration)	recommendation	using	the	similarity	factor	f2	
to	evaluate	the	similarity	of	drug	dissolution	profiles,40	the	similarity	factor	f2	was	introduced	to	evaluate	
the	performance	of	the	models	for	predicting	the	cumulative	drug	release	curves.	If	the	f2	is	greater	than	
or	equal	to	50,	it	is	considered	a	successful	prediction.	The	accuracy	of	the	cumulative	drug	release	curve	
prediction	is	the	percentage	of	the	successful	predictions	in	all	predictions:		
	 𝑎𝑐𝑐𝑢𝑟𝑎𝑐𝑦&'() = 𝑁𝑢𝑚𝑏𝑒𝑟(𝑓1 ≥ 50)𝐴𝑙𝑙𝑃𝑟𝑒𝑑𝑖𝑐𝑡𝑖𝑜𝑛𝑠 	
	
European	Pharmacopoeia	stipulates	that	orodispersible	tablets	are	the	tablets	that	could	disperse	within	
3min	(180s).	In	our	dataset,	the	disintegration	time	of	OFDF	ranges	from	0	to	100s.	Usually,	the	sucessful	
prediction	is	that	the	error	between	the	predicated	time	and	the	experiment	time	is	not	higher	than	10s.	
The	accuracy	of	the	disintegration	time	prediction	 is	 the	percentage	of	the	successful	predictions	 in	all	
predictions:		
	 𝑎𝑐𝑐𝑢𝑟𝑎𝑐𝑦'? = 𝑁𝑢𝑚𝑏𝑒𝑟 𝑓@ − 𝑓 ≤ 10𝐴𝑙𝑙𝑃𝑟𝑒𝑑𝑖𝑐𝑡𝑖𝑜𝑛𝑠 	
	
Where,	𝑓@	is	the	predicted	value,	𝑓	is	the	experimental	value.		
	
3.	Results	and	Discussion	
Deep	 learning	 is	 a	 type	 of	 representation	 learning	 with	 multiple	 levels	 of	 transform	 modules,	 which	
contains	more	parameters	than	other	learning	algorithms	and	requires	more	data	for	training.	However,	
one	 of	 the	 main	 difficulties	 in	 pharmaceutical	 formulation	 prediction	 is	 the	 small	 dataset	 with	
imbalanced	 input	 space	due	 to	 the	 limited	experimental	 data.	 Each	dosage	 form	has	only	 around	140	
formulations.	There	are	13	APIs	 in	the	OFDF	dataset,	29	APIs	 in	the	SRMT	dataset.	But	near	half	of	the	
APIs	 include	 less	 than	 four	 formulations.	 Therefore,	 selecting	 representative	 datasets	 for	 training	 and	
test	 is	 very	 important	 for	 the	 formulation	 prediction.	 In	 our	 research,	 the	 specific	 evaluation	 criteria	
were	 introduced	 and	 several	 data	 splitting	methods	 were	 investigated.	Moreover,	 deep	 learning	 was	
compared	with	other	machine	learning	techniques	for	the	formulation	prediction.	
3.1.	Random	Data	Splitting	
30%	data	were	randomly	selected	as	the	validation	set,	remaining	data	as	the	training	set.	This	
procedure	was	repeated	1000	times.	However,	entirely	different	accuracy	results	were	obtained,	the	
maximum	variation	of	accuracy	was	more	than	40%,	and	the	average	accuracy	was	less	than	60%.	In	the	
whole	dataset,	near	half	of	the	APIs	include	less	than	four	formulations.	Therefore,	random	data	splitting	
algorithm	has	near	50%	probability	to	select	these	APIs	with	less	formulations,	which	may	make	
prediction	accuracy	quite	low	and	high	variation.	In	short,	the	random	selection	algorithm	is	not	suitable	
for	our	research	and	a	new	approach	need	to	be	developed	to	select	the	representative	data.			
3.2.	Manual	Data	Splitting		
In	the	manual	dataset	selection,	formulation	experts	picked	up	20	representative	data	as	the	validation	
set	for	each	dosage	form.	All	prediction	accuracies	on	both	the	training	set	and	the	validation	set	were	
greater	than	90%.	However,	the	manual	selection	method	requires	domain	knowledge	of	experts,	which	
is	not	suitable	for	large	datasets	and	may	have	the	variation	from	different	experts.	Therefore,	a	
selection	algorithm	should	be	developed	to	select	the	validation	set	automatically.			
3.3.	Maximum	Dissimilarity	for	Data	Splitting		
Previous	research	showed	rational	selection	algorithm	can	generate	better	statistical	results	for	the	
validation	set	than	random	selection.41	Another	study	indicated	that	the	maximum	dissimilarity	
algorithm	was	able	to	select	representative	test	data	of	compounds	from	chemical	databases.42	The	
original	maximum	dissimilarity	algorithm	was	published	in	Caret	library	of	R	language.43	In	our	research,	
the	maximum	dissimilarity	algorithm	was	also	used	to	select	the	validation	set.	But	the	test	result	
showed	that	the	maximum	dissimilarity	algorithm	didn’t	work	well	on	our	data,	because	the	accuracies	
of	the	validation	set	were	only	83.46%	for	OFDF	and	78.85%	for	SRMT.	After	analyzing	the	splitting	result,	
it	was	found	that	the	maximum	dissimilarity	algorithm	preferred	to	select	the	data	from	a)	the	
formulations	in	small	API	groups,	b)	boundary	formulations,	and	c)	formulations	with	extraordinary	
values.	The	possible	reason	is	that	the	small	API	group	data,	the	boundary	data	or	the	abnormal	data	
have	bigger	dissimilar	values	than	other	data.	Moreover,	the	maximum	dissimilarity	algorithm	adopts	the	
randomly	generated	initial	set	to	compute	the	dissimilarity	degree,	which	is	still	highly	various	and	not	
robust	due	to	the	small	dataset.	Therefore,	the	original	maximum	dissimilarity	algorithm	should	be	
improved	to	select	the	representative	formulation	data.	
3.4.	MD-FIS	Algorithm	for	Data	Splitting		
A	new	algorithm	in	R	language	was	developed	for	selecting	the	best	representative	data	to	validate	the	
models.	Figure	1	shows	the	 improved	Maximum	Dissimilarity	algorithm	with	 the	small	group	 filter	and	
representative	initial	set	selection	(MD-FIS).	The	MD-FIS	algorithm	contains	3	steps.	 In	Step	1,	the	data	
go	 through	 a	 filter	 to	 get	 rid	 of	 the	 small	 API	 group	 data.	 In	 Step	 2,	 the	MD-FIS	 algorithm	 randomly	
generates	 10000	 initial	 datasets,	 computes	 the	 similarity	 values	 between	 the	 initial	 datasets	 and	 the	
remaining	datasets,	and	chooses	the	initial	set	with	the	highest	similarity	value	as	the	final	initial	set.	In	
step	3,	the	final	initial	set	and	the	remaining	data	set	are	used	as	the	input	to	the	dissimilarity	algorithm	
with	new	cost	function.	Different	from	the	original	cost	function,	new	cost	function	not	only	includes	the	
distances	 (originalDistance)	 between	 the	 candidate	 data	 and	 the	 initial	 set,	 but	 also	 contains	 the	
distances	(subMeanDistance)	between	the	candidate	data	and	the	remaining	data	in	the	same	API	group.	
The	new	cost	function	is:		 cost = originalDistance − 	𝛼 ∗ subMeanDistance	
Where,	𝛼	can	control	the	proportion	of	subMeanDistance,	the	maximum	dissimilarity	algorithm	selects	
the	data	with	the	maximum	cost.	The	new	cost	function	will	prevent	the	selection	of	the	boundary	data.	
The	 result	was	much	 better	 than	 that	 of	 the	 original	maximum	dissimilarity	 algorithm.	 The	 prediction	
accuracies	were	95.57%	for	OFDF	and	82.02%	for	SRMT	on	the	validation	set.		
	
Figure	1	The	workflow	of	MD-FIS	algorithm	
3.5.	Comparison	of	Deep	Learning	and	Conventional	Machine	Learning	Methods	
	
Table	2	Results	of	the	conventional	machine	learning	models	and	the	deep	neural	network	on	the	OFDF	
training,	validation	and	test	sets	
Machine	
learning	
techniques	
Training	Set	 Validation	Set	 Test	Set	
Accuracy	
(%)	
RMSE	 MAE	
Accuracy	
(%)	
RMSE	 MAE	
Accuracy	
(%)	
RMSE	 MAE	
MLR	 90.11	 0.0671		 0.0508	 60.00	 0.1311		 0.0999	 65.00	 0.1778		 0.1183	
PLSR	 76.92	 0.0917		 0.0705	 70.00	 0.1136		 0.0835	 70.00	 0.0970		 0.0705	
SVM	 79.12	 0.1136		 0.0711	 70.00	 0.1308		 0.0959	 75.00	 0.1039		 0.0795	
ANN	 74.73	 0.1140		 0.0809	 70.00	 0.1105		 0.0846	 70.00	 0.0959		 0.0772	
RF	 84.62	 0.0775		 0.0567	 80.00	 0.0917		 0.0721	 70.00	 0.1068		 0.0774	
k-NN	 80.22	 0.0975		 0.0649	 75.00	 0.1025		 0.0727	 75.00	 0.0877		 0.0608	
DNN	 97.80	 0.0420	 0.0307	 80.00	 0.0842	 0.0705	 80.00	 0.0714	 0.0565	
	
Table	3	Results	of	the	conventional	machine	learning	models	and	the	deep	neural	network	on	the	SRMT	
training,	validation,	and	test	sets	
Machine	
learning	
techniques	
Training	Set	 Validation	Set	 Test	Set	
Accuracy	
(%)	
RMSE	 MAE	
Accuracy	
(%)	
RMSE	 MAE	
Accuracy	
(%)	
RMSE	 MAE	
MLR	 52.38	 0.1356		 0.1031	 35.00	 0.1212		 0.1042	 25.00	 0.2182		 0.1685	
PLSR	 55.24	 0.1446		 0.1066	 55.00	 0.1175		 0.0961	 45.00	 0.1609		 0.1203	
SVM	 60.95	 0.1568		 0.1013	 50.00	 0.1170		 0.0960	 45.00	 0.1559		 0.1147	
ANN	 57.14	 0.1330		 0.0998	 50.00	 0.1389		 0.1137	 50.00	 0.1497		 0.1124	
RF	 76.19	 0.0975		 0.0692	 55.00	 0.1308		 0.1045	 55.00	 0.1170		 0.0908	
k-NN	 64.76	 0.1229		 0.0825	 45.00	 0.1526		 0.1264	 40.00	 0.1565		 0.1306	
DNN	 99.05	 0.0335	 0.0237	 80.00	 0.0967	 0.0660	 80.00	 0.0902	 0.0673	
	
	
	
In	this	study,	the	models	of	MLR,	PLSR,	SVM,	ANNs,	RF,	k-NN	and	deep	learning	were	developed	on	the	
formulation	data.	Here,	three	datasets	were	split	by	using	the	MD-FIS	algorithm	twice	without	the	need	
of	personal	expertise.	In	the	prediction	of	SRMT,	4	models	were	built	for	the	4	time	points	(2,	4,	6	and	8	
hours)	by	using	each	of	the	machine	learning	methods.	The	final	results	of	accuracies,	root	mean	squared	
errors	(RMSE)	and	mean	absolute	errors	(MAE)	were	shown	in	Table	2	and	Table	3.	In	the	prediction	of	
OFDF,	 for	all	 the	models	based	on	the	 linear	or	nonlinear	conventional	machine	 learning	methods,	the	
accuracies	 only	 reach	 around	 70%	 on	 the	 OFDF	 validation	 and	 test	 sets.	 As	 to	 the	 MLR	 model,	 the	
accuracies	are	 relatively	 low	than	other	conventional	machine	 learning	models	on	 the	OFDF	validation	
and	 test	 sets.	 In	 the	prediction	of	 SRMT,	 the	 conventional	machine	 learning	models	made	predictions	
with	the	accuracies	ranging	from	25%	to	55%	on	the	SRMT	validation	and	test	sets,	which	are	far	from	
the	satisfied	prediction	for	the	formulation	development.	In	summary,	all	these	six	conventional	machine	
learning	methods	could	not	achieve	enough	performance	for	the	OFDF	and	SRMT	formulation	prediction.	
Here,	the	training,	validation	and	test	sets	for	training	the	DNNs	are	the	same	as	the	datasets	used	for	
training	the	previous	machine	learning	models.	A	multi-label	model	was	built	for	the	4	time	points	(2,	4,	
6	and	8	hours)	using	deep	 learning	techniques.	As	shown	in	Table	2&3,	all	prediction	accuracies	of	the	
deep	 neural	 networks	 were	 over	 80%,	 which	 could	 satisfy	 the	 requirements	 of	 the	 formulation	
prediction.	In	both	OFDF	and	SRMT	predictions,	deep	learning	got	the	highest	accuracies	on	the	training,	
validation	and	test	sets.	Deep	learning	surpassed	other	conventional	machine	learning	methods	because	
deep	 learning	 including	multiple	 hidden	 layers	 could	 transform	 the	 low	 level	 representation	 to	 higher	
level	 features	 without	 artificial	 feature	 engineering.	 In	 SRMT	 prediction,	 huge	 performance	
improvements	of	deep	learning	were	found	than	other	machine	learning	methods.	The	result	 indicates	
that	 deep	 learning	 can	 greatly	 improve	 the	 model	 accuracy	 in	 multi-label	 formulation	 prediction,	
because	deep	learning	can	leverage	the	shared	information	among	the	multiple	tasks.	Figure	2	shows	the	
experimental	and	the	deep	 learning	predicted	disintegration	time	of	the	formulations	 in	the	OFDF	test	
set.	 Table	 4	 lists	 the	 f2	 values	 between	 the	 experimental	 and	 the	deep	 learning	predicted	 cumulative	
drug	released	curves	of	the	formulations	in	the	SRMT	test	set.	From	these	figures	and	tables,	it	is	quite	
clear	that	the	prediction	performance	of	deep	learning	is	satisfied.		
	
	Figure	2	Comparing	the	experimental	and	the	deep	learning	predicted	disintegration	time	of	the	
formulations	in	the	OFDF	test	set	
	
Table	4	f2	values	between	the	experimental	and	the	deep	learning	predicted	cumulative	drug	released	
curves	of	the	formulations	in	the	SRMT	test	set	
Formulation	 f2	values	 Formulation	 f2	values	
1	 77.42	 11	 65.72	
2	 63.35	 12	 90.05	
3	 64.84	 13	 57.05	
4	 67.21	 14	 41.91	
5	 59.75	 15	 55.06	
6	 50.85	 16	 65.84	
7	 77.77	 17	 51.08	
8	 30.39	 18	 49.57	
9	 44.56	 19	 64.42	
10	 74.47	 20	 59.35	
	
Figure	3,	4,	5	and	6	 show	the	 relationship	between	 the	experimental	and	 the	deep	 learning	predicted	
results	on	the	OFDF	and	SRMT	training,	validation	and	test	sets.	It	could	be	seen	from	these	figures	that	
the	experimental	and	the	deep	learning	predicted	values	are	very	closed.	
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	Figure	 3	 Relationship	 between	 the	 experimental	 and	 the	 deep	 learning	 predicted	 values	 of	 the	
disintegration	time	on	the	OFDF	training,	validation	and	test	sets.	The	dotted	line	indicates	experimental	
values	±	10s.	
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Figure	 4	 Relationship	 between	 the	 experimental	 and	 the	 deep	 learning	 predicted	 values	 of	 the	
cumulative	drug	release	percentages	at	2h,	4h,	6h,	8h	on	the	SRMT	training	set.	A	is	for	the	values	at	2h,	
B	is	for	the	values	at	4h,	C	is	for	the	values	at	6h,	D	is	for	the	values	at	8h.	
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Figure	 5	 Relationship	 between	 the	 experimental	 and	 the	 deep	 learning	 predicted	 values	 of	 the	
cumulative	drug	release	percentages	at	2h,	4h,	6h,	8h	on	the	SRMT	validation	set.	A	is	for	the	values	at	
2h,	B	is	for	the	values	at	4h,	C	is	for	the	values	at	6h,	D	is	for	the	values	at	8h.	
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Figure	 6	 Relationship	 between	 the	 experimental	 and	 the	 deep	 learning	 predicted	 values	 of	 the	
cumulative	drug	release	percentages	at	2h,	4h,	6h,	8h	on	the	SRMT	test	set.	A	is	for	the	values	at	2h,	B	is	
for	the	values	at	4h,	C	is	for	the	values	at	6h,	D	is	for	the	values	at	8h.	
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Multiple	linear	regression	attempts	to	learn	a	linear	combination	of	input	features	to	predict	the	output.	
Multiple	 linear	 regression	 is	 simple	 and	 easy	 to	 model.	 The	 weights	 and	 biases	 of	 multiple	 linear	
regression	 could	 be	 directly	 calculated	 by	 using	 the	 least	 squares	 method.	Multiple	 linear	 regression	
have	 better	 interpretability	 than	 other	 nonlinear	machine	 learning	models	 because	 the	weights	 could	
indicate	the	importance	of	the	input	features	in	the	prediction.	However,	multiple	linear	regression	and	
partial	least	squared	regression	could	only	could	only	fit	the	linear	function	mapping,	while	obviously	the	
relationship	between	the	formulation	and	the	key	in	vitro	characteristics	is	complex	and	non-linear.	
Random	 forest	 is	 an	 ensemble	 learning	method.	 Ensemble	 learning	methods	 combining	multiple	 base	
learners	could	obtain	better	generalization	ability	of	models	than	a	single	base	 learner.	Random	forest	
usually	 shows	 better	 performance	 than	 other	 ensemble	 learning	 models	 in	 many	 learning	 tasks.	 In	
random	forest,	the	diversity	of	the	base	learners	is	not	only	from	the	sample	disturbance	but	also	from	
the	 attribute	 disturbance,	 which	 makes	 the	 difference	 between	 the	 base	 learners	 increase	 and	 the	
generalization	ability	be	 further	 improved.	Support	vector	machine	maps	 the	sample	 from	the	original	
space	 to	 the	 higher	 dimensional	 feature	 space,	 therefore,	 the	 sample	 can	 be	 divided	 in	 the	 higher	
dimensional	 feature	 space.	 However,	 the	 conventional	 machine	 learning	 methods	 highly	 rely	 on	 the	
feature	extractors	designed	by	the	subjective	expert	experiences.	
Furthermore,	the	representative	abilities	of	artificial	neural	networks	enhance	with	the	increase	of	the	
hidden	layers	and	hidden	nodes.	The	larger	the	model	capacity,	the	more	complex	function	the	model	
can	achieve.	Therefore,	deep	learning	containing	more	hidden	layers	could	make	multiple	abstractions	
and	feature	extractions,	which	makes	deep	learning	be	able	to	accomplish	more	complex	tasks	to	higher	
accuracy	than	the	shallow	artificial	neural	networks.	
3.6.	Deep	Learning	in	Formulation	Prediction	
One	main	difficulty	of	 formulation	prediction	 is	the	 lack	of	reliable	and	standard	formulation	data.	The	
long	experimental	 cycle	and	high	cost	of	 formulation	development	 results	 in	 the	 small	data	 set	 in	 this	
area.	Moreover,	 current	 formulation	 researches	 focus	on	 small	 amount	of	model	drugs,	which	 lead	 to	
highly	 imbalanced	data	 space	 and	 further	 rise	 the	 difficulty	 of	 formulation	 prediction	 for	 other	 drugs.	
This	 fundamental	 issue	was	 reported	 in	previous	 research,	 in	which	 the	data	 sets	are	 too	small	or	 too	
noisy.30	 To	 solve	 the	 issue,	 10-fold	 cross	 validation	 was	 used	 for	 assessing	 the	 performance	 of	 the	
algorithm,	which	 the	R2	 value	only	 reached	0.67	or	0.69.30,	44	 The	prediction	 is	 even	weaker	 in	 smaller	
data	 set	 because	 the	 small	 data	 set	 easily	 results	 in	 overfitting	 and	 poor	 generalizations.30	
suggestion	was	to	increase	the	amount	of	data	set	30,	but	there	are	very	limited	formulation	data	due	to	
the	experimental	 limitation.	Euclidean	distance	was	used	to	estimate	the	domain	of	applicability	of	the	
trained	 model.30	 Another	 study	 indicated	 that	 maximum	 dissimilarity	 algorithm	 was	 able	 to	 select	
representative	 testing	 data	 of	 compounds	 from	 chemical	 databases.42	 However,	 both	 methods	 were	
good	for	the	drug	molecules,	not	for	highly	complexity	formulation	data.	Deep	learning	with	usual	data	
selection	 algorithms	 and	 evaluation	 criteria	 is	 difficult	 to	 well	 predict	 with	 the	 small	 amount	 of	
formulation	 data	 with	 imbalanced	 input	 space.	 Therefore,	 MD-FIS	 algorithm	 is	 suitable	 for	 splitting	
formulation	 data	 with	 small	 sample	 size	 and	 imbalanced	 input	 space.	 In	 addition,	 two	 common	
evaluation	 metrics	 for	 regression	 problems	 (e.g.	 the	 correlation	 coefficient	 and	 coefficient	 of	
determination)	 cannot	 reflect	 the	 performance	 of	 pharmaceutical	 prediction	 models.	 Specific	 criteria	
need	to	be	introduced	for	evaluating	the	model	performance.	
Currently	 there	 are	 only	 two	 deep	 learning	 researches	 in	 formulation	 prediction.25,	 44	 In	 Zawbaa’s	
research,	 68	 poly-lactide-co-glycolide	 formulations	were	 used.	 Input	 vector	 contains	 320	 features	 and	
745	release	data	at	specific	time	points.	At	the	beginning,	the	feature	selection	models	were	developed	
to	minimize	the	input	variables.44After	that,	seven	machine	learning	approaches	were	compared,	such	as	
cubist,	RF,	ANNs,	multivariate	adaptive	 regression	spline,	 classification	and	 regression	 tree,	and	hybrid	
systems	 of	 fuzzy	 logic	 and	 evolutionary	 computations.	 The	 final	 results	 showed	 RF	 had	 the	 best	
performance	with	0.692	coefficient	of	determination.	Moreover,	 the	prediction	of	 the	model	was	only	
suitable	for	2/3	formulations	and	the	rest	1/3	formulations	had	high	error.	The	dissolution	profiles	of	4	
proteins	 among	 total	 14	 proteins	 were	 strongly	 not	 recommended	 by	 the	 final	 model.	 Formulation	
development	 contains	high	dimensional	 factors,	 such	as	drug	diversity,	 excipient	 types,	drug/excipient	
ratios,	 dosage	 forms,	 manufacturing	 processes	 and	 multiple	 characteristics,	 which	 lead	 to	 the	 high	
complexity	data.	Actually,	deep	 learning	can	automatically	 learn	high	 level	 features	 from	data	without	
explicitly	providing	 feature	 selection	model.	Combining	 feature	extractors	with	deep	 learning	model	 is	
unnecessary	 and	 inappropriate.	 Therefore,	 this	 research	 still	 needs	 significant	 improvement	 on	
methodology	 for	 formulation	 prediction.	 Recently	 deep	 learning	 with	 MD-FIS	 was	 applied	 for	
formulation	 prediction	 of	 oral	 fast	 disintegrating	 tablets.25	 The	 results	 showed	 that	 the	 prediction	 of	
deep	 learning	 was	 better	 than	 that	 of	 ANN	 because	 deep	 learning	 could	 extract	 the	 features	
automatically	 without	 designing	 feature	 extractors.	 In	 addition,	 there	 are	 some	 researches	 about	
machine	 learning	 methods	 in	 formulation	 design,	 as	 summarized	 in	 Table	 1.	 For	 example,	 an	 expert	
system	was	constructed	to	predict	formulations	of	oral	disintegrating	tablets	with	15	input	parameters.12,	
13	 Zhi-hong	 Zhang	 et	 al.	 built	 an	 expert	 system	 with	 ANN	 for	 the	 formulation	 development	 of	 oral	
osmotic	 pump	 controlled	 release	 tablets.	 5,	 14	 QSAR	 models	 were	 developed	 to	 predict	 the	 binding	
affinity	 of	 β-cyclodextrin	 and	 sulfobutylether-β-cyclodextrin	 complexation.	 However,	 these	 results	
indicated	that	the	conventional	machine	learning	methods	need	feature	extraction	before	the	prediction	
models	and	didn’t	showed	good	prediction	performance.		
	
4.	Conclusion	
In	this	paper,	deep	learning	models	were	successfully	developed	to	predict	pharmaceutical	formulations	
on	 small	data.	The	good	generalization	performance	of	 the	models	was	demonstrated	by	 the	external	
datasets.	The	proposed	models	could	effectively	predict	 the	key	characteristics	 in	 regression	problems	
than	 the	models	 trained	 by	 other	machine	 learning	methods,	 because	 deep	 learning	 can	 find	 out	 the	
complex	 correlation	 in	 the	 data.	 Quality	 by	 design	 (QbD)	 is	 one	 concept	 that	 the	 idea	 of	 the	
pharmaceutical	 development	 should	 be	 paid	 attention	 throughout	 the	 drug	 development	 process.	
Machine	learning	methods	could	not	only	help	to	predict	the	in	vivo	and	in	vitro	characteristics	based	on	
the	formulation	and	process	data,	but	also	assist	 in	the	pharmaceutical	experiment	design	and	help	to	
control	 the	 product	 quality	 in	 the	whole	 product	 cycle.	 Deep	 learning	 shows	 a	 broad	 prospect	 in	 the	
implementation	 of	 QbD.	 We	 expect	 deep	 learning	 could	 significantly	 shorten	 the	 drug	 product	
development	timeline	and	decrease	the	material	usage.	Furthermore,	the	cross-disciplinary	 integration	
of	 pharmaceutics	 and	 artificial	 intelligence	may	 shift	 the	paradigm	of	 pharmaceutical	 researches	 from	
experience-dependent	 studies	 to	 data-driven	 methodologies.	 In	 the	 future,	 our	 laboratory	 would	
investigate	other	machine	learning	methods	(e.g.	transfer	learning)	for	formulation	prediction	to	achieve	
better	performance.	
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